Innovating Works

ABIEL

Desconocido
ARTIBLED: Engineered ARTIficial proteins for Biological Light Emitting Diodes ABIEL SOCIETA A RESPONSABILITA LIMITATA participó en un H2020: H2020-FETOPEN-2018-2020 The EU priority action lines state the need of advancing white light-emitting diodes (WLED) replacing color filters with inorganic phosphors...
2019-08-30 - 2024-12-31 | Financiado
FutForm: Future Formulations Developing Future Pharmaceuticals Through Advanced Analysis and Intersectoral E... ABIEL SOCIETA A RESPONSABILITA LIMITATA participó en un H2020: H2020-MSCA-RISE-2015 The estimated cost of getting a new medicine to market is now in excess of $2.6 billion, with an additional $300 million (approx.) typically...
2015-10-28 - 2020-03-31 | Financiado
DRIVE: Diabetes Reversing Implants with enhanced Viability and long term Efficacy ABIEL SOCIETA A RESPONSABILITA LIMITATA participó en un H2020: H2020-NMP-2014-2015 Diabetes mellitus is a chronic disease characterised by high blood glucose due to inadequate insulin production and/or insulin resistance wh...
2015-05-13 - 2019-05-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.